000			01928 a2200505 4500
005			20250516171322.0
264		0	_c20140811
008			201408s 0 0 eng d
022			_a1873-2402
024	7		_a10.1016/j.biopsych.2013.08.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aFranklin, Aimee V
245	0	0	_aGlycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice. _h[electronic resource]
260			_bBiological psychiatry _cFeb 2014
300			_a198-206 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCognition _xdrug effects
650	0	4	_aCognition Disorders _xdrug therapy
650	0	4	_aDisease Models, Animal
650	0	4	_aDisks Large Homolog 4 Protein
650	0	4	_aElectric Stimulation
650	0	4	_aExcitatory Amino Acid Antagonists _xpharmacology
650	0	4	_aFragile X Mental Retardation Protein _xgenetics
650	0	4	_aFragile X Syndrome _xcomplications
650	0	4	_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors
650	0	4	_aGuanylate Kinases _xmetabolism
650	0	4	_aHippocampus _xpathology
650	0	4	_aIn Vitro Techniques
650	0	4	_aLithium Chloride _xpharmacology
650	0	4	_aLong-Term Potentiation _xdrug effects
650	0	4	_aMembrane Proteins _xmetabolism
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aPatch-Clamp Techniques
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aSynapses _xdrug effects
700	1		_aKing, Margaret K
700	1		_aPalomo, Valle
700	1		_aMartinez, Ana
700	1		_aMcMahon, Lori L
700	1		_aJope, Richard S
773	0		_tBiological psychiatry _gvol. 75 _gno. 3 _gp. 198-206
856	4	0	_uhttps://doi.org/10.1016/j.biopsych.2013.08.003 _zAvailable from publisher's website
999			_c23093530 _d23093530